JP5415660B2 - Method for producing yeast thioredoxin - Google Patents
Method for producing yeast thioredoxin Download PDFInfo
- Publication number
- JP5415660B2 JP5415660B2 JP2004253030A JP2004253030A JP5415660B2 JP 5415660 B2 JP5415660 B2 JP 5415660B2 JP 2004253030 A JP2004253030 A JP 2004253030A JP 2004253030 A JP2004253030 A JP 2004253030A JP 5415660 B2 JP5415660 B2 JP 5415660B2
- Authority
- JP
- Japan
- Prior art keywords
- yeast
- trx
- thioredoxin
- ultrafiltration membrane
- kda
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
本発明は、TRX高含有酵母抽出液から酵母チオレドキシンの調製を迅速かつ簡便に行うことを特徴とする、新規な酵母チオレドキシンの製造方法に関する。より詳細には、負荷培養等により得られたチオレドキシン高含有酵母から調製した抽出物を、更に限外濾過膜を用いることにより、酵母チオレドキシンを高濃度に含有する画分を調製し、酵母チオレドキシンを迅速かつ簡便に調製することを可能にすることを特徴とする、新規な酵母チオレドキシンの製造方法に関する。 The present invention relates to a novel method for producing yeast thioredoxin, characterized in that yeast thioredoxin is quickly and easily prepared from a yeast extract containing a high TRX content. More specifically, an extract prepared from thioredoxin-rich yeast obtained by load culture or the like was further used to prepare a fraction containing yeast thioredoxin at a high concentration by using an ultrafiltration membrane. The present invention relates to a method for producing a novel yeast thioredoxin, which enables rapid and simple preparation.
チオレドキシン(以下「TRX」)とは、高度に保存されたC-X-Y-Cの活性中心(特にX:Gly、Y:Pro)を持つ、約12kDaの電子伝達タンパク質であり、ほとんどの生物の細胞内に存在することが知られている(非特許文献1から4)。TRXは他のタンパク質に存在するジスルフィド結合の酸化還元活性を有し、その酸化還元活性によりタンパク質の活性や機能、性質を調節する機能を有する。
Thioredoxin (hereinafter referred to as “TRX”) is an approximately 12 kDa electron transfer protein with a highly conserved CXYC active center (especially X: Gly, Y: Pro), and is present in the cells of most organisms. It is known (
様々なストレス、特に酸化ストレスは脂質・遺伝子・タンパク質などの生体高分子に傷害を与え、細胞・組織に害を及ぼすが、それに伴いTRXの体内での濃度が変化することが知られている。すなわち体内でのTRX濃度の上昇により、各種ストレスにより生じたアレルギーの改善もしくは予防、粘膜の保護もしくは修復、皮膚の保護等がなされると考えられている。 Various stresses, especially oxidative stress, damages biological macromolecules such as lipids, genes, and proteins and causes damage to cells and tissues. It is known that the concentration of TRX in the body changes accordingly. That is, it is considered that an increase in TRX concentration in the body can improve or prevent allergies caused by various stresses, protect or repair mucous membranes, protect skin, and the like.
TRXが有する酸化還元活性を応用した様々な技術が現在までに開示されている。例えばTRXによる各種アレルゲンの中和(特許文献1)、TRXによる転写因子AP-1の活性化(特許文献2)、TRXによるアレルギー予防、皮質改善、粘膜障害保護(特許文献3)、炎症疾患の予防ないし治療(特許文献4)等が開示されている。 Various techniques using the redox activity of TRX have been disclosed so far. For example, neutralization of various allergens by TRX (Patent Document 1), activation of transcription factor AP-1 by TRX (Patent Document 2), allergy prevention by TRX, cortical improvement, protection of mucosal disorders (Patent Document 3), inflammatory diseases Prevention or treatment (Patent Document 4) is disclosed.
上述のようなTRXの性質を利用し、TRXを機能性食品素材として応用することが可能であると考えられる。しかしながらTRXを産業的なスケールで製造する場合には、克服しなければならない課題が存在する。すなわち酵母抽出物からTRXを精製するには、通常は数種類のクロマトグラフィを組み合わせることにより行うが、クロマトグラフィを行うためには多大な設備、原料物質、労力もしくは時間を要するため、より簡便かつ効率的なTRXの精製方法が求められていた。すなわち本発明が解決しようとする問題点は、酵母抽出物からTRXを簡便かつ効率的に精製する方法を確立することである。 It is considered that TRX can be applied as a functional food material by utilizing the properties of TRX as described above. However, when manufacturing TRX on an industrial scale, there are challenges that must be overcome. That is, to purify TRX from yeast extract, it is usually performed by combining several types of chromatography. However, since chromatography requires a lot of equipment, raw materials, labor or time, it is simpler and more efficient. A method for purifying TRX was desired. That is, the problem to be solved by the present invention is to establish a method for simply and efficiently purifying TRX from yeast extract.
本発明者らは、鋭意研究の結果、TRX高含有酵母を培養し得られた菌体を破砕して調製した酵母抽出液を、限外濾過膜を用い濾過をすることより、酵母TRXを含有する画分と含有しない画分に分離することができ、その結果酵母TRXを迅速かつ簡便に調製することが可能となることを見出し、本発明を完成するに至った。課題を解決するための手段は、以下の通りである。
(1) チオレドキシン高含有酵母の菌体を破砕して得た酵母細胞抽出液を遠心分離し、得られた上清画分を、限外濾過膜を用いて少なくとも一回以上濾過し、チオレドキシンを含有する画分と含有しない画分とに分離する工程を含むことを特徴とする、酵母チオレドキシンの製造方法。
(2) 限外濾過膜を用いて濾過する工程が、分画分子量5〜6kDaの限外濾過膜により濾過する工程により構成されることを特徴とする、前記(1)に記載の方法。
(3) 限外濾過膜を用いてチオレドキシンを含有する画分を調製する工程が、分画分子量5〜6kDaの限外濾過膜により濾過する工程及び分画分子量100kDaの限外濾過膜により濾過する工程により構成されることを特徴とする、前記(1)に記載の方法。
(4) 限外濾過膜を用いてチオレドキシンを含有する画分を調製する工程が、分画分子量1000kDaの限外濾過膜により濾過する工程、分画分子量100kDaの限外濾過膜により濾過する工程及び分画分子量5〜6kDaの限外濾過膜により濾過する工程により構成されることを特徴とする、前記(1)に記載の方法。
(5) チオレドキシンを含有する画分を調製する工程後、左記画分に含まれる総タンパク質に占めるチオレドキシン含有量が、0.1〜25質量%であることを特徴とする、前記(1)から(4)のいずれかに記載の方法。
As a result of diligent research, the inventors of the present invention have included yeast TRX by filtering a yeast extract prepared by crushing bacterial cells obtained by culturing yeast with high TRX content using an ultrafiltration membrane. As a result, it was found that yeast TRX can be quickly and easily prepared, and the present invention has been completed. Means for solving the problems are as follows.
(1) The yeast cell extract obtained by crushing yeast cells containing a high thioredoxin content is centrifuged, and the resulting supernatant fraction is filtered at least once using an ultrafiltration membrane to obtain thioredoxin. A method for producing yeast thioredoxin, comprising a step of separating into a fraction containing and a fraction not containing.
(2) The method according to (1) above, wherein the step of filtering using an ultrafiltration membrane comprises a step of filtering through an ultrafiltration membrane having a molecular weight cut off of 5 to 6 kDa.
(3) The step of preparing a fraction containing thioredoxin using an ultrafiltration membrane is a step of filtering through an ultrafiltration membrane having a fractional molecular weight of 5 to 6 kDa, and a step of filtering through an ultrafiltration membrane having a fractional molecular weight of 100 kDa. The method according to (1) above, comprising a step.
(4) The step of preparing a fraction containing thioredoxin using an ultrafiltration membrane is a step of filtering through an ultrafiltration membrane having a fractional molecular weight of 1000 kDa, a step of filtering through an ultrafiltration membrane having a fractional molecular weight of 100 kDa, and The method according to (1) above, comprising a step of filtering through an ultrafiltration membrane having a molecular weight cut off of 5 to 6 kDa.
(5) After the step of preparing a fraction containing thioredoxin, the thioredoxin content in the total protein contained in the left fraction is 0.1 to 25% by mass, from (1) above (4) The method in any one of.
本発明は、TRX高含有酵母を培養し得られた菌体を破砕して調製した酵母抽出物を、更に限外濾過膜を用い分離を行うことを特徴とする、酵母TRXの製造方法である。本発明により、酵母チオレドキシンを高濃度に含有する画分が調製され、その結果酵母TRXを迅速かつ簡便に調製することが可能となる。 The present invention is a method for producing yeast TRX, characterized in that the yeast extract prepared by crushing the cells obtained by culturing yeast with high TRX content is further separated using an ultrafiltration membrane. . According to the present invention, a fraction containing yeast thioredoxin at a high concentration is prepared, and as a result, yeast TRX can be prepared quickly and easily.
TRXとは、一般には高度に保存されたC-X-Y-Cの活性中心(特にX:Gly、Y:Pro)を有し、生体内の種々の酸化還元反応に関わる、ほとんどの生物の細胞中に存在する電子伝達タンパク質の総称(TRXファミリー)を指す。 TRX generally has a highly conserved active center of CXYC (especially X: Gly, Y: Pro), and is an electron present in the cells of most organisms involved in various redox reactions in vivo. It refers to the generic term for transfer proteins (TRX family).
本発明のTRXタンパク質は、本明細書に記載した特徴を有する限り、その製法や給源などは特に限定されない。すなわち本発明のTRXタンパク質は、天然由来のもの、遺伝子工学的手法に生産される組換えタンパク質、あるいは化学合成タンパク質のいずれでも本発明の課題を解決することは可能である。ただし、安全性確認が容易な天然供給源から得られるTRX、望ましくは酵母由来のTRX、より望ましくはパン酵母、ビール酵母、ワイン酵母、清酒酵母及び味噌醤油酵母などの食用酵母、更に望ましくはパン酵母(Saccharomyces cerevisiae)由来のTRXである。 As long as the TRX protein of the present invention has the characteristics described in the present specification, its production method, supply source and the like are not particularly limited. That is to say, the TRX protein of the present invention can solve the problems of the present invention by using any naturally derived protein, recombinant protein produced by genetic engineering techniques, or chemically synthesized protein. However, TRX obtained from a natural source whose safety can be easily confirmed, preferably TRX derived from yeast, more preferably edible yeast such as baker's yeast, beer yeast, wine yeast, sake yeast and miso soy yeast, and more preferably baker's yeast TRX derived from yeast (Saccharomyces cerevisiae).
また、上記酵母としては食用酵母が望ましく、例えばサッカロミセス(Saccharomyces)属、トルロプシス(Torulopsis)属、ミコトルラ(Mycotorula)属、トルラスポラ(Torulaspora)属、キャンディダ(Candida)属、ロードトルラ(Rhodotorula)属、ピキア(Pichia)属などが挙げられる。これらの酵母に、緑茶抽出物や過酸化水素・t-ブチルハイドロパーオキサイドなどの過酸化物によって酵母にストレスを強制的に負荷し、酵母中のTRX含量を高めた酵母を使用する。 Further, preferably edible yeast as the yeast, for example Saccharomyces (Saccharomyces) genus Torulopsis (Torulopsis) genus Mikotorura (Mycotorula) genus Torulaspora (Torulaspora) genus Candida (Candida) genus Rhodotorula (Rhodotorula) genus Pichia ( Pichia ) genus etc. are mentioned. For these yeasts, a yeast in which stress is forcibly applied to the yeasts by peroxides such as green tea extract or hydrogen peroxide / t-butyl hydroperoxide to increase the TRX content in the yeasts is used.
酵母TRXタンパク質は、典型的には、酵母Saccharomyces cerevisiaeのTRX2タンパク質のアミノ酸配列(Genbank登録番号AAA85584(U40843),thioredox…[gi:1165214],Jae Mahn Songら、24-Jan-1996)に記載のように、104アミノ酸により構成された配列を有する。しかしながら天然のタンパク質の中にはそれを生産する生物種の品種の違いや、生態系の違いによる遺伝子の変異、あるいはよく似たアイソザイムの存在などに起因して1から複数個のアミノ酸変異を有する変異タンパク質が存在することは周知であり、例えばSaccharomyces属の他の種に属する酵母、あるいは他の属、例えば、ピキア属等に属する種の酵母由来のTRXも本発明において使用しうる。なお、本明細書で使用する用語「アミノ酸変異」とは、1以上のアミノ酸の置換、欠失、挿入及び/又は付加などを意味する。本発明の酵母TRXタンパク質は典型的には上記Genbank登録番号AAA85584(U40843)に記載のアミノ酸配列を有するが、その配列を有するタンパク質のみに限定されるわけではなく、本明細書中に記載した特性を有する限り全ての相同タンパク質を含むことが意図される。相同性は少なくとも70%以上、好ましくは80%以上、より好ましくは90%以上である。 The yeast TRX protein is typically described in the yeast Saccharomyces cerevisiae TRX2 protein amino acid sequence (Genbank accession number AAA85584 (U40843), thioredox ... [gi: 1165214], Jae Mahn Song et al., 24-Jan-1996). Thus, it has a sequence composed of 104 amino acids. However, some natural proteins have one or more amino acid mutations due to differences in the varieties of species that produce them, genetic mutations due to differences in ecosystems, or the presence of similar isozymes. It is well known that mutant proteins exist, and for example, yeast belonging to other species of the genus Saccharomyces, or TRX derived from yeasts of other genera such as the genus belonging to the genus Pichia can also be used in the present invention. As used herein, the term “amino acid mutation” means substitution, deletion, insertion and / or addition of one or more amino acids. The yeast TRX protein of the present invention typically has the amino acid sequence described in the above Genbank accession number AAA85584 (U40843), but is not limited to the protein having that sequence, and the characteristics described herein. It is intended to include all homologous proteins as long as The homology is at least 70% or more, preferably 80% or more, more preferably 90% or more.
酵母の培養の方法としては、公知の方法、例えばバッチ培養、流加連続培養、流加バッチ培養などが挙げられる。培養は、ジャーファーメンターを用いて好適に行うことができ、このときのジャーファーメンターにおける条件としては、特に制限はなく適宜決定することができるが、例えば、培養温度としては28〜33℃程度であり、培養時間としては1〜120時間程度であり、pHとしては4〜7程度であり、通気量としては0〜5vvm程度であり、攪拌速度としては100〜700rpm程度である。そして、上記酵母の培養において、培地中に各種ストレス性物質を添加して、酵母菌体内のTRX含量を通常の2倍程度(300μg/g)以上に高めておくことが必要である。 Examples of yeast culture methods include known methods such as batch culture, fed-batch continuous culture, and fed-batch culture. The culture can be suitably performed using a jar fermenter, and the conditions in the jar fermenter at this time are not particularly limited and can be appropriately determined. For example, the culture temperature is about 28 to 33 ° C. The culture time is about 1 to 120 hours, the pH is about 4 to 7, the aeration amount is about 0 to 5 vvm, and the stirring speed is about 100 to 700 rpm. In the yeast culture, it is necessary to add various stress substances to the medium to increase the TRX content in the yeast cells to about twice (300 μg / g) or more than usual.
酵母の培養に用いる培地及び流加培養の際に用いる流加液としては、特に制限はなく、目的に応じて公知のものの中から適宜選択することができ、例えば、廃糖蜜などが好適に挙げられる。なお、それらは炭素源、窒素源等を適宜含んでいてもよい。培養中に行うストレス負荷方法としては、通常、緑茶抽出物またはその成分を添加する方法があり、そうすることで酵母菌体中のTRX含量を2倍以上に上げる事ができる。 The medium used for yeast culture and the fed-batch solution used during fed-batch culture are not particularly limited and can be appropriately selected from known ones according to the purpose. It is done. In addition, they may contain a carbon source, a nitrogen source and the like as appropriate. As a stress loading method performed during culture, there is usually a method of adding a green tea extract or a component thereof, and by doing so, the TRX content in the yeast cells can be increased by 2 times or more.
酵母細胞の破砕の方法としては、顕微鏡観察下で未破砕菌体がなくなればよく、特に制限はなく目的に応じて適宜選択することができ、例えば、凍結−解凍の繰り返し、音波処理、機械的崩壊、又は細胞溶解剤の使用を含む適当な慣用的方法であってもよく、具体的には、0.5mm径のビーズをシリンダーに50容量%充填したダイノミルを用いる方法などが好適に挙げられる。 As a method for disrupting yeast cells, it is sufficient that unbroken cells are eliminated under microscopic observation, and there is no particular limitation, and it can be appropriately selected according to the purpose. For example, repeated freeze-thawing, sonication, mechanical A suitable conventional method including disintegration or use of a cell lysing agent may be used, and specifically, a method using a dynomill in which 50% by volume of 0.5 mm-diameter beads are filled in a cylinder is preferable. .
前記ダイノミルとしては、特に制限はなく目的に応じて適宜選択することができるが、例えば、WAB社製のDynomill Model Type KDLなどが挙げられ、前記シリンダーの容量としては、特に制限はなく目的に応じて適宜選択することができるが、例えば実験的には0.6リットル程度である。前記銅高含有酵母の懸濁液(30%(w/v))の前記ダイノミルにおける前記シリンダー内への流速としては、例えば2.16リットル/時間程度が好ましい。また、酵母の前記ダイノミルにおける前記シリンダー内での滞在時間としては、10分間程度が好ましい。なお、前記破砕の前に、イオン交換水で前記ダイノミルにおける前記シリンダー内を予め洗浄しておくのが好ましい。また、前記顕微鏡観察下での未破砕菌体の有無は、適宜サンプリングをして顕微鏡観察を行うことにより確認することができる。更に必要に応じてデスラッジャー等を用いて不純物を除去しても良い。 The dynomill is not particularly limited and may be appropriately selected according to the purpose. Examples thereof include Dynamyl Model Type KDL manufactured by WAB, and the capacity of the cylinder is not particularly limited and depends on the purpose. For example, it is about 0.6 liters experimentally. The flow rate of the copper-rich yeast suspension (30% (w / v)) into the cylinder in the dynomill is preferably, for example, about 2.16 liter / hour. Moreover, as a residence time in the said cylinder in the said dynomill of yeast, about 10 minutes are preferable. In addition, it is preferable to wash | clean the inside of the said cylinder in the said dynomill previously with ion-exchange water before the said crushing. In addition, the presence or absence of unbroken cells under the microscope observation can be confirmed by appropriately sampling and performing a microscope observation. Further, impurities may be removed using a deslagger or the like as necessary.
次に、上記のように得られた酵母細胞破砕液を、限外濾過膜を用いて濾過することにより、TRXを高濃度で含有する抽出物を調製する。使用する限外濾過膜は、平膜式、管状膜式、中空糸膜式などが使用可能であるが、TRX回収の迅速性の意味から、平膜式の限外濾過膜を使用するのが望ましい。 Next, an extract containing TRX at a high concentration is prepared by filtering the yeast cell disrupted liquid obtained as described above using an ultrafiltration membrane. As the ultrafiltration membrane to be used, a flat membrane type, a tubular membrane type, a hollow fiber membrane type, etc. can be used. From the viewpoint of rapid TRX recovery, a flat membrane type ultrafiltration membrane should be used. desirable.
なお、限外濾過膜を使用してTRX高含有抽出物を調製する際、異なる分画分子量の限外濾過膜を複数組み合わせて濾過を行うのが望ましい。組み合わせる限外濾過膜は、分画分子量が1000kDa、100kDa及び5〜6kDaのものを、その順番で組み合わせるのが望ましい。なお、組み合わせる限外濾過膜の種類が1種類または2種類の場合は十分な濃縮効果が得られず、また4種類以上組み合わせてもそれに見合うだけの効果が得られない。この方法により、総タンパク質に占めるチオレドキシン含有量を0.1〜25質量%にすることが可能となる。 In addition, when preparing an extract with a high TRX content using an ultrafiltration membrane, it is desirable to perform filtration by combining a plurality of ultrafiltration membranes having different fractional molecular weights. As for the ultrafiltration membrane to be combined, those having a molecular weight cut-off of 1,000 kDa, 100 kDa, and 5 to 6 kDa are desirably combined in that order. In addition, when there are one or two types of ultrafiltration membranes to be combined, a sufficient concentration effect cannot be obtained, and even when four or more types are combined, an effect commensurate with it cannot be obtained. By this method, the thioredoxin content in the total protein can be 0.1 to 25% by mass.
限外濾過膜による濃縮を行った後、更に必要であれば、酵母TRXの精製は、塩析、イオン交換、アフィニティ精製又はゲル濾過精製の慣用される方法を適当に組み合わせることにより実施される。あるいは最終精製工程としてRP−HPLCを用いてもよい。 After concentration by ultrafiltration membrane, if necessary, purification of yeast TRX is carried out by appropriately combining conventional methods of salting out, ion exchange, affinity purification or gel filtration purification. Alternatively, RP-HPLC may be used as the final purification step.
酵母の培養
本実施例においては、酵母の培養の際にストレス負荷を与えることにより、酵母細胞中のTRX含量が増加するか否かを、実験室レベルにおいて検討した。市販のパン酵母であるO−102(受託番号:FERM P−18569)(オリエンタル酵母工業製)をSD培地(16φ試験管5ml)に1白金耳植菌し、30℃、2日間培養後、H培地(1%グルコース、0.2%酵母エキス、0.5%ペプトン、0.03% K2HPO4、0.03% KH2PO4、0.01% MgCl2)坂口フラスコ100mLにOD610≒0.05となるように植菌した。30℃で14時間培養(OD610≒4.5)後、市販の緑茶抽出物「サンフェノンBG」(太陽化学株式会社製)を終濃度2.0%となるように添加し、次いで5N NaOHを用いてpH7.6となるように調整した。その後、30℃で90分問振とう培養を行った。得られた菌体0.3gを蒸留水0.3mlおよびほぼ等料のガラスビーズ(φ0.5mm)と混合し、Fast Prep(Qbiogen社製)で30秒激しく振とうして細胞を破砕し、更に遠心分離を行い、上清を得た。左記の上清を用い、後述の実施例3の方法によりTRX濃度を測定したところ、ストレス負荷を行わずに培養を行った場合と比較し2倍程度増加していた。
Yeast Culture In this example, whether or not the TRX content in yeast cells was increased by applying a stress load during yeast culture was examined at the laboratory level. Commercially available baker's yeast O-102 (Accession Number: FERM P-18869) (manufactured by Oriental Yeast Co., Ltd.) was inoculated with 1 platinum ear in SD medium (16 mm test tube 5 ml), cultured at 30 ° C. for 2 days, A medium (1% glucose, 0.2% yeast extract, 0.5% peptone, 0.03% K2HPO4, 0.03% KH2PO4, 0.01% MgCl2) was inoculated into a 100 mL Sakaguchi flask so that OD610≈0.05. After culturing at 30 ° C. for 14 hours (OD610≈4.5), a commercially available green tea extract “Sunphenon BG” (manufactured by Taiyo Chemical Co., Ltd.) was added to a final concentration of 2.0%, and then pH 7.6 using 5N NaOH. It adjusted so that it might become. Thereafter, shaking culture was performed at 30 ° C. for 90 minutes. 0.3 g of the obtained microbial cells were mixed with 0.3 ml of distilled water and approximately equal glass beads (φ0.5 mm), and the cells were disrupted by shaking vigorously with Fast Prep (Qbiogen) for 30 seconds. Further centrifugation was performed to obtain a supernatant. When the TRX concentration was measured by the method of Example 3 to be described later using the left supernatant, it was increased about twice as compared with the case where the culture was performed without applying stress.
酵母の破砕
実施例1と同様の培養条件で、30Lジャーファーメンターにスケールアップした培養を行い、得られた酵母菌体1kgを蒸留水4Lに懸濁した酵母懸濁液(湿菌体20%)5Lを調製した。左記酵母懸濁液をガラスビーズ(φ0.5mm)をチェンバー容量の50重量%相当分詰めた細胞破砕装置(Dynomill Model KDL社製、チェンバー容量0.6L)で細胞を破砕した。なお、チェンバー内での酵母懸濁液の滞留時間は10分間とし、冷却条件は循環冷却方式(2℃)とした。また上記破砕後の酵母破砕液を遠心分離し、その上清画分5Lを調製した。
Yeast disruption Under the same culture conditions as in Example 1, the culture was scaled up to a 30 L jar fermenter, and 1 kg of the obtained yeast cells were suspended in 4 L of distilled water (wet cells 20%). ) 5L was prepared. Cells were disrupted with a cell disruption device (Dynomill Model KDL, chamber capacity 0.6 L) in which the yeast suspension was filled with glass beads (φ0.5 mm) corresponding to 50% by weight of the chamber capacity. The residence time of the yeast suspension in the chamber was 10 minutes, and the cooling condition was a circulating cooling system (2 ° C.). Moreover, the yeast crushing liquid after the said crushing was centrifuged and the supernatant fraction 5L was prepared.
平膜による濃縮
実施例2において得られた上清画分を、1000kDa、100kDa及び5kDaの分画分子量の限外濾過膜を用いて濾過を行った。限外濾過装置は「ポールTFF限外濾過カセットシステム」(日本ポール株式会社製)を用いた。作業工程の大まかな流れ、及びその作業工程の各段階における抽出液中のTRX含量及び純度等を図1に示す。
Concentration by flat membrane The supernatant fraction obtained in Example 2 was filtered using ultrafiltration membranes with fractional molecular weights of 1000 kDa, 100 kDa and 5 kDa. As the ultrafiltration device, “Pole TFF ultrafiltration cassette system” (manufactured by Nippon Pole Co., Ltd.) was used. FIG. 1 shows the rough flow of the work process, and the TRX content and purity in the extract at each stage of the work process.
なお、試料中のTRX濃度の測定は、以下の手順により行った。
1) R1(300μL)と試料(20μL)を混合
2) 25℃で5分間予備加熱
3) R2(6μL)を添加し、混合
4) 25℃で1分間インキュベートし、その間におけるAbs340の減少を測定
(R1とは、0.1M Tris-HCl(pH7.0)、2mM EDTA、0.8mg/mLインシュリン、0.16mM NADPH溶液のことを指す。またR2とは、0.3U/mL NTR(NADP依存チオレドキシンレダクターゼ)、0.1M Tris-HCl(pH7.0)溶液のことを指す。)
The TRX concentration in the sample was measured according to the following procedure.
1) Mix R1 (300 μL) and sample (20 μL) 2) Preheat 5 min at 25 ° C. 3) Add R2 (6 μL) and mix 4)
最終的に乾燥残物中の含有率が0.72質量%、タンパク質成分中の純度が1.13質量%のTRX高含有抽出物を得た。TRXを高濃度で含有するため、それ以降の精製工程が簡便になり、TRX精製品の調製が迅速かつ簡便になった。 Finally, a high TRX content extract having a content of 0.72% by mass in the dry residue and a purity of 1.13% by mass in the protein component was obtained. Since TRX is contained at a high concentration, the subsequent purification steps are simplified, and preparation of purified TRX products is quick and simple.
本発明の酵母TRXの製造方法は、酵母TRXを高濃度で含有する酵母抽出物を容易に得る工程を含むため、酵母TRXの製造を迅速かつ簡便に行うことが可能となった。これにより酵母TRXの製造コストの削減、製造期間の短縮などの経済効果が期待できる。 Since the method for producing yeast TRX of the present invention includes a step of easily obtaining a yeast extract containing yeast TRX at a high concentration, yeast TRX can be produced quickly and easily. As a result, economic effects such as reduction in the production cost of yeast TRX and shortening of the production period can be expected.
Claims (1)
チオレドキシンを含有する画分を調製する工程後、左記画分に含まれる総タンパク質に占めるチオレドキシン含有量が、0.1〜25質量%である
ことを特徴とする、
酵母チオレドキシンの製造方法。 A yeast cell extract obtained by crushing yeast cells containing thioredoxin-rich yeast was centrifuged, and the resulting supernatant fraction was (1) an ultrafiltration membrane with a molecular weight cut-off of 1000 kDa; (2) a molecular weight cut-off 100 kDa ultrafiltration membrane; and (3) Separation into fractions containing thioredoxin and fractions not containing thioredoxin, consisting of filtration in this order by ultrafiltration membrane with a molecular weight cut off of 5-6 kDa Including steps , and
After the step of preparing a fraction containing thioredoxin, the thioredoxin content in the total protein contained in the left fraction is 0.1 to 25% by mass.
It is characterized by
A method for producing yeast thioredoxin.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004253030A JP5415660B2 (en) | 2004-08-31 | 2004-08-31 | Method for producing yeast thioredoxin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004253030A JP5415660B2 (en) | 2004-08-31 | 2004-08-31 | Method for producing yeast thioredoxin |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006067850A JP2006067850A (en) | 2006-03-16 |
JP5415660B2 true JP5415660B2 (en) | 2014-02-12 |
Family
ID=36149117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004253030A Active JP5415660B2 (en) | 2004-08-31 | 2004-08-31 | Method for producing yeast thioredoxin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5415660B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009178087A (en) * | 2008-01-30 | 2009-08-13 | Kyoto Univ | Method for producing liquors or fermented seasoning |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0220295A (en) * | 1988-07-08 | 1990-01-23 | Chisso Corp | Production of free epsilon-polylysine |
JPH02128687A (en) * | 1988-11-08 | 1990-05-17 | Tosoh Corp | Treatment of inert type protein using ultrafiltration membrane |
JPH06261783A (en) * | 1993-03-16 | 1994-09-20 | Toyota Central Res & Dev Lab Inc | Specific monoclonal antibody to thiorefoxin |
JP4790891B2 (en) * | 2000-02-02 | 2011-10-12 | オリエンタル酵母工業株式会社 | Thioredoxin composition stable in solution and process for its preparation |
KR100467068B1 (en) * | 2002-03-06 | 2005-01-24 | 정명준 | Lactococcus lactis CBT-19, manufacturing method of the culture broth concentration and the cosmetic preparation |
JP2004008130A (en) * | 2002-06-10 | 2004-01-15 | Pola Chem Ind Inc | Serum-free culture medium for cell culture |
-
2004
- 2004-08-31 JP JP2004253030A patent/JP5415660B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2006067850A (en) | 2006-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5282581B2 (en) | Modified flavin adenine dinucleotide-dependent glucose dehydrogenase | |
Bricker et al. | Isolation of a highly active photosystem II preparation from Synechocystis 6803 using a histidine-tagged mutant of CP 47 | |
US9260699B2 (en) | Glucose dehydrogenase | |
JP6079038B2 (en) | Novel glucose dehydrogenase | |
JP4248900B2 (en) | Novel gene encoding fructosylamine oxidase and method for producing fructosylamine oxidase using the same | |
CN110628738B (en) | Method for improving activity of glucose oxidase, mutant and application thereof | |
WO2010032492A1 (en) | Koji mold alkaline protease promoter | |
JP5415660B2 (en) | Method for producing yeast thioredoxin | |
JP6101011B2 (en) | Method for improving the stability of a composition comprising a flavin-binding glucose dehydrogenase | |
EP0783578B1 (en) | Yeast with modified permeability | |
JP4586164B2 (en) | Neisseria gonorrhoeae-derived phospholipase A2 | |
JP2018033399A (en) | Method of producing brewing yeast with high isoamyl acetate productivity, acetic acid productivity of low productivity, and high isoamyl alcohol productivity | |
JP3819969B2 (en) | Recombinant fructosyl amino acid oxidase | |
JP2002017351A (en) | Phosphohexuloisomerase and its gene | |
JP6979484B2 (en) | Recombinant microorganisms for producing 2,3-butanediol and methods for producing 2,3-butanediol | |
CN112410353A (en) | fkbS gene, genetic engineering bacterium containing fkbS gene, and preparation method and application of fkbS gene | |
JP4412658B2 (en) | Thioredoxin-rich yeast and method for producing the same | |
JP2785084B2 (en) | Method for producing squalene-producing yeast and novel yeast produced | |
JP6499587B2 (en) | Transformant, method for producing the same, and method for producing lactic acid | |
US20100330631A1 (en) | Cis-aconitate Decarboxylase Mutants Having Improved Enzymatic Activity | |
JPH11318438A (en) | Recombined microorganism 3-hydroxybutyric acid dehydrogenase, its production and its use | |
KR101460566B1 (en) | Saccharomyces sp. AFY-1 producing fibrinolytic enzyme and soy sauce that cotains it | |
JP5995218B2 (en) | Sorbitol-inducible promoter | |
JP6305735B2 (en) | Method for improving ceramide productivity and method for producing ceramide | |
CN104342408A (en) | Preparation method of recombinant cordyceps sinensis superoxide dismutase (rcSOD) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20070726 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20080312 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20080425 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20080425 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100317 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100514 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110412 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110712 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20110819 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20110914 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20111111 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20131114 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5415660 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313117 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |